Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
NXE-0033744 by Nxera Pharma for Crohn's Disease (Regional Enteritis): Likelihood of Approval
NXE-0033744 is under clinical development by Nxera Pharma and currently in Phase I for Crohn's Disease (Regional Enteritis). According to...